Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Recombinant expression of human desmocyte growth factor-21

A growth factor and expression carrier technology, applied in the field of recombinant expression of human fibroblast growth factor-21, can solve the problems of affecting protein activity, difficulties in medical research and drug development, and low product recovery rate

Active Publication Date: 2010-02-03
杭州生长因子医药科技有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The product recovery rate obtained by this process is very low, which also affects the protein activity
At present, foreign studies have shown that the expression of FGF-21 mainly exists in the form of inclusion bodies, which brings difficulties to medical research and drug development

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant expression of human desmocyte growth factor-21
  • Recombinant expression of human desmocyte growth factor-21
  • Recombinant expression of human desmocyte growth factor-21

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] PCR synthesis of embodiment 1 FGF-21 gene

[0038] According to the amino acid sequence of FGF-21 gene with signal peptide removed, primers were designed, and the FGF-21 gene with signal peptide removed was obtained by complementary extension. According to the degeneracy of codons, the enzyme cutting sites used in this experiment were eliminated, and the online software Primer Finder and DNA STAR were used to design FGF-21 primers, a total of 14 (see the sequence listing for its nucleotide sequence), every two There is a 20bp complementary sequence between the strips, and the N-terminal primer contains a complementary sequence to the Sumo molecular chaperone. The FGF-21 gene was synthesized by bridge PCR.

[0039] FGF-21 gene synthesis

[0040] PCR system one:

[0041] 10×pfu buffer 10μl

[0042] dNTP (2.5mM) 8μl

[0043] Primer F1 (10μmol) 2μl

[0044] Primer R1 (10μmol) 2μl

[0045] pfu DNA polymerase 0.5μl

[0046] ddH2O 77.5μl

[0047] Total 100μl

[004...

Embodiment 2

[0066] Example 2 Construction of pET-20b-Sumo-FGF-21 expression vector

[0067] In order to fuse the synthetic FGF-21 gene with the Sumo molecular chaperone, the synthetic primer P1 was designed according to the N-terminal of the Sumo sequence, and the primer P2 was designed according to the C-terminal of the FGF-21 gene. In the reaction system containing the FGF-21 gene and the Sumo molecular chaperone, Using P1 and P2 as primers, the fusion gene containing Sumo-FGF-21 was amplified by PCR. Then the fragment was double-digested with NdeI and XhoI, and ligated with the pET-20b plasmid that was also double-digested with the two enzymes.

[0068] Nucleotide sequences of primers P1 and P2:

[0069] P1: 5'GGAATTCCATATGCATCATCATCATCATCATCACG 3'

[0070] P2: 5' CCGCTCGAG TCAGGAAGCGTAGCTGGGGCT 3'

[0071] PCR reaction system:

[0072] 10×pfu buffer 2μl

[0073] dNTP (2.5mM) 2μl

[0074] Primer P1 (10μmol) 1μl

[0075] Primer P2 (10μmol) 1μl

[0076] FGF21 sequence: 0.5μl

[...

Embodiment 3

[0082] Embodiment 3: the acquisition of recombinant FGF-21 protein

[0083] 1. Induced expression

[0084]The correctly sequenced pET-20b-Sumo-FGF21 was transformed into Escherichia coli BL21(DE3) competent cells, and positive transformants were screened on an ampicillin resistance plate. A single colony of the screened positive recombinant bacteria BL21(DE3) / pET-20b-Sumo-FGF-21 was inoculated into LB medium and cultured with shaking at 37°C for 16h. Then it was transferred to fresh LB medium at a ratio of 5%, and the expression conditions such as temperature, IPTG concentration and induction time were optimized. Studies have confirmed that when the OD value is 0.6, 1mM IPTG is induced at 37°C for 3 hours, ultrasonic (100w, ultrasonic 2s, interval 2s) breaks the bacteria, and the soluble expressed target protein can account for more than 90% of the total bacterial target protein.

[0085] 2. Protein Purification

[0086] According to the above-mentioned optimal conditions f...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
purityaaaaaaaaaa
Login to View More

Abstract

The invention relates to a method for recombinating and expressing human fibroblast growth factors, which comprises following steps: fusing an FGF-21 gene and a molecular chaperone Sumo sequence, building a new prokaryotic expression vector, transforming escherichia coli, thereby building engineering bacteria, and obtaining the FGF-21 through culturing the engineering bacteria and inducing expression. The method of the invention can promote soluble expression of protein, which is beneficial for folding recombined protein correctly and is convenient for separating and purifying the protein. Activity detection proves that the recombined protein which is obtained has comparatively high biological activity and the bioactivity is equivalent to the bioactivity of FGF21standard products.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to the recombinant expression of human fibroblast growth factor-21. Background technique [0002] Fibroblast growth factor (FGF) is a class of structurally related proteins encoded by members of the FGF gene family. At present, 23 members have been found, and their central regions all contain a segment with a homology of 30%-70%. amino acid sequence. The members of the large FGF family, as intercellular multifunctional signaling molecules, regulate various physiological functions of organisms. [0003] FGF-21, a new member of the FGF family, is a secretable protein that was first isolated from mouse embryos. The human FGF-21 cDNA encodes 209 amino acids, which has about 75% homology with the mouse FGF-21 amino acid. The amino acid sequence of human FGF-21 has 35% and 24% homology with FGF-19 and FGF-23, respectively. FGF-21, FGF-19 and FGF-23 are closely related to fat metabolism, a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/62C12N15/63C12N1/21C07K14/50A61K38/18A61P3/10A61P3/04A61P35/00C12R1/19
Inventor 李校堃肖业臣王会岩张耀方
Owner 杭州生长因子医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com